908 Devices Inc., a commercial-stage technology company, provides various purpose-built handheld and desktop mass spectrometry (Mass Spec) devices to interrogate unknown and invisible materials in life sciences research, bioprocessing, industrial biotech, forensics, and adjacent markets. The company's products include MX908, a handheld, battery-powered, and Mass Spec device that is designed for rapid analysis of gas, liquid, and solid materials of unknown identity; Rebel, a small desktop analyzer that provides real-time information on the extracellular environment in bioprocesses; and ZipChip solution, a plug-and-play, high-resolution separation platform that optimizes Mass Spec sample analysis. It operates in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company was incorporated in 2012 and is headquartered in Boston, Massachusetts.
P/E ratio for 908 Devices Inc. (MASS)
P/E ratio as of 2023: -9.94
According to 908 Devices Inc.'s latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is -9.94. At the end of 2022 the company had a P/E ratio of -7.56.
P/E ratio history for 908 Devices Inc. from 2018 to 2023
PE ratio at the end of each year
| Year | P/E ratio |
|---|---|
| 2023 | -9.94 |
| 2022 | -7.56 |
| 2021 | -32.70 |
| 2020 | -223.93 |
| 2019 | -84.44 |
| 2018 | -123.43 |